Interleukin-10 receptor A (IL-10RA), Natural Killer Cell Receptor 2B4 (CD244), and urokinase-type plasminogen activator (uPA) may contribute to the occurrence of prostatitis, while Interleukin-12B (IL-12B) appears to serve as a protective factor against it. Here, PLAU is linked to urogenital neoplasm.